Xtl Biopharmaceuticals annual operating margin
2024
Xtl Biopharmaceuticals Operating Margin Growth & History (XTLB)
Xtl Biopharmaceuticals's operating margin was −481.60% for fiscal 2024.
View full Xtl Biopharmaceuticals company overviewXtl Biopharmaceuticals annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2024 | 2024-12-31 | −481.60% | — |
Xtl Biopharmaceuticals quarterly operating margin
Q4.24
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q4 2024 | 2024-12-31 | −280.97% | — |
Xtl Biopharmaceuticals operating margin trends
The latest reported quarter, Q4 2024, shows −280.97%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Xtl Biopharmaceuticals source filings ↗